Patterns of practice for acute myocardial infarction in a population from ten countries

European Journal of Clinical Pharmacology

Volumn 54, Issue 11, 1999, Pages 877-886

  Venturini, F ^a   Romero, M ^a   Tognoni, G ^a  

^a c/o Consorzio Mario Negri Sud ^*  (Italy)

Author keywords

Aspirin; Beta adrenergic blocking agents; Drug utilization; Myocardial infarction; Pharmacists; Thrombolytic therapy

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG CONTRAINDICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHARMACIST; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ASPIRIN; CANADA; DATA COLLECTION; EUROPE; FEMALE; FIBRINOLYTIC AGENTS; GUIDELINES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; STREPTOKINASE;

EID: 0032942280     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050570     Document Type: Article

References (33)

1. 1. GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico) (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet i: 397-401
2. 2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet ii: 349-60
3. 3. ISIS-1 (First International Study of infarct Survival) Collaborative Group (1986) Randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet ii: 57-65
4. 4. GISSI-3 (Gruppo Italiano per Io Studio della Sopravvivenza nell'Infarto miocardico) (1994) Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-weeks mortality and ventricular function after myocardial infarction. Lancet 343: 1115-1122
5. 5. ISIS-4 (Fourth International Study of Infarct Survival) (1995) ISIS-4; a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58, 050 patients with suspected acute myocardial infarction. Lancet 345: 669-685
6. 6. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (1996) ACC/AHA Guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol 28: 1328-1428
7. 7. The task force on the management of acute myocardial infarction of the European Society of Cardiology (1996) Acute myocardial infarction: pre-hospital and in -hospital management. Eur Heart J 17: 43-63
8. 8. Boissel JP (1989) Impact of randomized clinical trials on medical practices. Control Clin Trials 10: 120S-134S
9. 9. Gurwitz JH, Col NF, Avorn J (1992) The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 268: 1417-1422
10. 10. Ketley D, Woods KL (1993) Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction. Lancet 342: 891-894
11. 11. Zahn R, Rustige J, Koch A, et al. (1997) Influence of the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-1) trial on the use of thrombolytics in Germany. Am J Cardiol 80: 1339-1343
12. 12. Rogers WJ, Bowlby LJ, Chandra NC, et al. (1994) Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the national registry of myocardial infarction. Circulation 90: 2103-2114
13. 13. European Secondary Prevention Study Group (1996) Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction. Lancet 347: 1203-1207
14. 14. McLaughlin TJ, Soumerai SB, Willison DJ, et al. (1996) Adherence to national guidelines for drug treatment of suspected acute myocardial infarction. Arch Intern Med 156: 799-805
15. 15. French JK, Williams BF, Hart HH, et al. (1996) Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. BMJ 312: 1637-1641
16. 16. Pilote L, Racine N, Hlatky MA (1994) Differences in the treatment of myocardial infarction in the United States and Canada. Arch Intern Med 154: 1090-1096
17. 17. Ayanian JZ, Guadagnoli E, McNeil BJ, Cleary PD (1997) Treatments and outcome of acute myocardial infarction among patients of cardiologists and generalist physicians. Arch Intern Med 157: 2570-2576
18. 18. Birkhead JS (1997) Thrombolytic treatment for myocardial infarction: an examination of practice in 39 United Kingdom hospitals. Heart 78: 28-33
19. 19. Venturini F, Romero M, Tognoni, G (1995) Acute myocardial infarction treatments in 58 Italian hospitals: a drug utilization survey. Ann Pharmacother 29: 1100-1105
20. 20. Green JA (1988) Drug-use evaluation of thrombolytic agents: a challenge to pharmacists. Am J Hosp Pharm 45: 2192-2194
21. 21. Beaglehole R, Stewart AW, Butler M (1987) Comparability of old and new World Health Organization criteria for definite myocardial infarction. Int J Epidemiol 16: 373-376
22. 22. SAS Institute (1989) SAS, STAT User Guide, Version 6, Fourth Edition, SAS Institute, Cary, N.C., USA
23. 23. The Global Utilization of Streptokinase and tPA for Occluded Coronary Arteries (GUSTO) Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329: 673-682
24. 24. Tsuyuki RT, Gills S, Hilton D (1994) Patterns of practice analysis for acute myocardial infarction. Can J Cardiol 10: 891-896
25. 25. Krumholz HM, Radford MJ, Ellerbeck EF, et al. (1995) Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries. Circulation 92: 2841-2847
26. 26. Sakethou BB, Conte FJ, Noris M, et al. (1997) Emergency department use of aspirin in patients with possible acute myocardial infarction. Ann Intern Med 127: 126-129
27. 27. Danchin N, Vaur L, Genès N, et al. (1997) Management of acute myocardial infarction in intensive care units in 1995; a nationwide French survey of practice and early hospital results. J Am Coll Cardiol 30: 1598-1605
28. 28. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group (1994) Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 343: 311-322
29. 29. Collins R, Peto R, Baigent C, Sleight P (1997) Aspirin, heparin and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med 336: 847-860
30. 30. Chandra H, Yarzebski J, Goldberg RJ, et al. (1997) Age-related trends (1986 1995) in the use of thrombolytic agents in patients with acute myocardial infarction. Arch Intern Med 157: 741-746
31. 31. GISSI - Avoidable Delay Study Group (1995) Epidemiology of avoidable delay in the care of patients with acute myocardial infarction. Arch Intern Med 155: 1481-1488
32. 32. Hannaford PC, Kay CR, Ferry C (1994) Agism as explanation for sexism in provision of thrombolysis. BMJ 309: 573-574
33. 33. GISSI-2 (Gruppo Italiano per Io Studio della Sopravvivenza nell'Infarto miocardico) (1990) GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction. Lancet 336: 65-71